Clinical Trials Directory

Trials / Completed

CompletedNCT01907516

Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Hawaii Pacific Health · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare compliance and satisfaction between a traditional method of blood glucose reporting using voicemail (control) and a novel method using cell phone /internet (Confidant) technology in the management of diabetic pregnant women.

Detailed description

Control of blood glucose levels is beneficial during pregnancy, however, the ability to effectively monitor patient's blood glucose levels is challenging and time consuming for patients and care providers. Patients must keep track of their own glucose levels and take the initiative to check blood glucose multiple times per day. Traditionally, patients record their glucose levels in a logbook, which they bring with them during an office visit or use to report their glucose levels over the phone. Non compliance and factitious reporting are not uncommon. Obstetricians and or diabetes program staff spend hours communicating with patients to obtain and record glucose values therefore alternatives to phone calls are needed. Investigators performed a prospective randomized cross over study comparing a conventional voicemail (control) system for home glucose reporting with a cell phone/internet reporting system (Confidant). The primary outcome measure was compliance with home blood glucose fingerstick reporting. Compliance was determined by the number of home glucose fingersticks reported / expected (%). The secondary outcome was patient satisfaction. Subjects were participants in the Kapiolani Medical Center for Women and Children's diabetes in pregnancy program known as "A Sweeter Choice". IRB approval was obtained before starting the study and all subjects received informed consent. The study was funded by Hawai'i Medical Service Association, a medical insurance company in Hawaii. The Confidant equipment was supplied by Hookele Personal Health Planners, LLC. None of the Ho'okele or Hawaii Medical Service Association staff were involved in data collection or analysis. Study subjects were randomized to Confidant or the control system at the entry into the diabetes program during consultation with the Maternal Fetal Medicine physician. After randomization, subjects performed the assigned monitoring system for 3 weeks. After three weeks, they switched to the other monitoring system. A satisfaction survey was completed after three weeks on the second system was completed.

Conditions

Interventions

TypeNameDescription
DEVICECell phone-internet home glucose reporting systemGlucose monitoring via cell phone and internet using the Confidant Diabetes Management Application and the Confidant Connector.
BEHAVIORALVoicemail home blood glucose reportingGlucose monitoring via standard telephone and fax reporting.

Timeline

Start date
2009-02-01
Primary completion
2010-08-01
Completion
2011-06-01
First posted
2013-07-25
Last updated
2015-06-03
Results posted
2015-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01907516. Inclusion in this directory is not an endorsement.